2 ms·
biomarker validation is just as annoying as drug testing, so you're just punting the problem one node down. it's hard work: http://blogs.sciencemag.org/pipelin
by hprotagonist 10y ago
biomarker validation is just as annoying as drug testing, so you're just punting the problem one node down.
it's hard work: http://blogs.sciencemag.org/pipeline/archives/2013/12/04/cancer_cell_line_assays_you_wont_like_hearing_this http://blogs.sciencemag.org/pipeline/archives/2013/12/04/can...
nominal biomarkers can be wholly spurious: http://blogs.sciencemag.org/pipeline/archives/2012/04/10/biomarker_caution http://blogs.sciencemag.org/pipeline/archives/2012/04/10/bio...
biomarkers that we believe to be proxies for disease conditions (like LDL) can be targeted to no effect: http://blogs.sciencemag.org/pipeline/archives/2016/12/14/simple-right http://blogs.sciencemag.org/pipeline/archives/2016/12/14/sim...
etc.